Avoid hormones in gastrointestinal angiodysplasia [6]

Lancet

Volumn 360, Issue 9341, 2002, Pages 1254-

  Grant, Ellen C G ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; ESTRADIOL; ESTROGEN; GESTAGEN; NORETHISTERONE; SEX HORMONE; ZINC;

AGE; ANGIODYSPLASIA; ARTERIOLE; BLEEDING; CARDIOVASCULAR RISK; DRUG CONTRAINDICATION; ESTROGEN THERAPY; GASTROINTESTINAL INFECTION; HUMAN; INFECTION RISK; LETTER; MORBIDITY; PRIORITY JOURNAL; SMOKING AND SMOKING RELATED PHENOMENA; THROMBOSIS; VASCULAR DISEASE;

EID: 0037136937     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11260-8     Document Type: Letter

References (5)

1. Hodgson H. Hormonal therapy for gastrointestinal angiodysphasia. Lancet. 359:2002;1630-1631.
2. Grant E.C.G. The pill, hormone replacement therapy, vascular and mood over-reactivity and mineral imbalance. J Nutr Environ Med. 8:1998;105-116.
3. Anon. Further analyses of mortality in oral contraceptive users: Royal College of General Practitioners' Oral Contraception Study. Lancet 1981; 1: 541-46.
4. Incidence of arterial disease among oral contraceptive users: Royal College of General Practitioners' Oral Contraception Study. J R Coll Gen Pract 1983; 33: 75-82.
5. Irey N.S., Manion W.C., Taylor H.B. Vascular lesions in women taking oral contraceptives. Arch Pathol. 89:1970;1-9.